STRIDE-DB

Repeat Length	AFR	AMR	EUR	EAS	SAS	Repeat
23.0	6	0	4	3	2	CTGCTGCTGCTGCTGCTGCTGCTGCTGTTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTG
12.0	0	0	2	0	0	CTGCTGCTGCTGCTGCTGCTGCTGCTGTTGCTGCTG
13.0	0	0	0	2	0	CTGCTGCTGCTGCTGCTGCTGCTGCTGTTGCTGCTGCTG
15.0	2	0	2	0	0	CTGCTGCTGCTGCTGCTGCTGCTGCTGTTGCTGCTGCTGCTGCTG
17.0	2	0	2	0	0	CTGCTGCTGCTGCTGCTGCTGCTGCTGTTGCTGCTGCTGCTGCTGCTGCTG
18.0	2	0	0	0	0	CTGCTGCTGCTGCTGCTGCTGCTGCTGTTGCTGCTGCTGCTGCTGCTGCTGCTG
19.0	0	0	2	0	0	CTGCTGCTGCTGCTGCTGCTGCTGCTGTTGCTGCTGCTGCTGCTGCTGCTGCTGCTG
20.0	2	0	0	0	0	CTGCTGCTGCTGCTGCTGCTGCTGCTGTTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTG
21.0	0	0	3	6	2	CTGCTGCTGCTGCTGCTGCTGCTGCTGTTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTG
22.0	22	16	15	25	18	CTGCTGCTGCTGCTGCTGCTGCTGCTGTTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTG

Position	Disease/Trait	P-value	SNPs	Location with respect to STR	distance	Study
12:111989658	Liver enzyme levels (alkaline phosphatase),	9.0E-46	rs666727	downstream	-47097	Genetic analysis in European ancestry individuals identifies 517 loci associated with liver enzymes.
12:111991249	Lymphocyte counts,	1.0E-18	rs61944388	downstream	-45506	Genetic determinants of blood-cell traits influence susceptibility to childhood acute lymphoblastic leukemia.
12:111993712	Myocardial infarction,	9.0E-9	rs7969300	downstream	-43043	Identification of 13 novel susceptibility loci for early-onset myocardial infarction, hypertension, or chronic kidney disease.
12:111994852	Low-carbohydrate diet (LCD) score,	4.0E-9	rs11065950	downstream	-41903	A genome-wide association study on adherence to low-carbohydrate diets in Japanese.
12:112003695	Mean corpuscular volume,	1.0E-9	rs615134	downstream	-33060	The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
12:112007756	Diastolic blood pressure,	1.0E-7	rs653178	downstream	-28999	Genetic analyses of diverse populations improves discovery for complex traits.
12:112007756	Systemic lupus erythematosus,	7.0E-9	rs653178	downstream	-28999	Transancestral mapping and genetic load in systemic lupus erythematosus.
12:112007756	CD45RA- CD4+ T cell Absolute Count,	1.0E-8	rs653178	downstream	-28999	Complex genetic signatures in immune cells underlie autoimmunity and inform therapy.
12:112007756	Crohn's disease,	7.0E-8	rs653178	downstream	-28999	Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.
12:112007756	Inflammatory bowel disease,	1.0E-8	rs653178	downstream	-28999	Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.
12:112007756	Eosinophil counts,	1.0E-180	rs653178	downstream	-28999	The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
12:112007756	Crohn's disease,	7.0E-7	rs653178	downstream	-28999	Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease.
12:112007756	Inflammatory bowel disease,	2.0E-9	rs653178	downstream	-28999	Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease.
12:112007756	Eosinophil percentage of granulocytes,	4.0E-126	rs653178	downstream	-28999	The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
12:112007756	Neutrophil percentage of granulocytes,	5.0E-108	rs653178	downstream	-28999	The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
12:112007756	Sum eosinophil basophil counts,	7.0E-167	rs653178	downstream	-28999	The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
12:112007756	Sarcoidosis,	2.0E-10	rs653178	downstream	-28999	Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk.
12:112007756	Monocyte count,	1.0E-43	rs653178	downstream	-28999	The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
12:112007756	Asthma,	1.0E-10	rs653178	downstream	-28999	Genome-wide analysis highlights contribution of immune system pathways to the genetic architecture of asthma.
12:112007756	Allergic disease (asthma, hay fever or eczema),	3.0E-14	rs653178	downstream	-28999	Genome-wide association analysis of 350 000 Caucasians from the UK Biobank identifies novel loci for asthma, hay fever and eczema.
12:112007756	Hay fever and/or eczema,	1.0E-15	rs653178	downstream	-28999	Genome-wide association analysis of 350 000 Caucasians from the UK Biobank identifies novel loci for asthma, hay fever and eczema.
12:112007756	Lymphocyte counts,	0	rs653178	downstream	-28999	Trans-ethnic and Ancestry-Specific Blood-Cell Genetics in 746,667 Individuals from 5 Global Populations.
12:112007756	LDL cholesterol,	4.0E-20	rs653178	downstream	-28999	Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program.
12:112007756	Total cholesterol levels,	2.0E-22	rs653178	downstream	-28999	Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program.
12:112007756	Chronic kidney disease,	4.0E-11	rs653178	downstream	-28999	New loci associated with kidney function and chronic kidney disease.
12:112007756	Diastolic blood pressure,	3.0E-18	rs653178	downstream	-28999	Genome-wide association study identifies eight loci associated with blood pressure.
12:112007756	Celiac disease,	7.0E-21	rs653178	downstream	-28999	Multiple common variants for celiac disease influencing immune gene expression.
12:112007756	Celiac disease or Rheumatoid arthritis,	3.0E-19	rs653178	downstream	-28999	Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci.
12:112007756	Celiac disease,	8.0E-8	rs653178	downstream	-28999	Newly identified genetic risk variants for celiac disease related to the immune response.
12:112007756	Urate levels,	7.0E-12	rs653178	downstream	-28999	Genome-wide association analyses identify 18 new loci associated with serum urate concentrations.
12:112007756	Blood pressure,	7.0E-20	rs653178	downstream	-28999	Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure.
12:112007756	Myocardial infarction,	3.0E-11	rs653178	downstream	-28999	A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease.
12:112007756	Diastolic blood pressure,	5.0E-7	rs653178	downstream	-28999	Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation.
12:112007756	Diastolic blood pressure,	1.0E-8	rs653178	downstream	-28999	Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation.
12:112007756	Eosinophil percentage of white cells,	3.0E-120	rs653178	downstream	-28999	The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
12:112007756	Urate levels,	2.0E-54	rs653178	downstream	-28999	Urate, Blood Pressure, and Cardiovascular Disease: Evidence From Mendelian Randomization and Meta-Analysis of Clinical Trials.
12:112007756	Neutrophil-to-lymphocyte ratio,	8.0E-64	rs653178	downstream	-28999	Genetic determinants of blood-cell traits influence susceptibility to childhood acute lymphoblastic leukemia.
12:112007756	Brain shape (segment 1),	1.0E-9	rs653178	downstream	-28999	Shared heritability of human face and brain shape.
12:112007756	Cortical surface area,	1.0E-17	rs653178	downstream	-28999	Vertex-wise multivariate genome-wide association study identifies 780 unique genetic loci associated with cortical morphology.
12:112007756	Psoriasis or type 2 diabetes (trans-disease meta-analysis),	5.0E-8	rs653178	downstream	-28999	Causal relationship and shared genetic loci between psoriasis and type 2 diabetes through trans-disease meta-analysis.
12:112007756	Thyroid peroxidase antibody levels,	1.0E-7	rs653178	downstream	-28999	Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease.
12:112007756	Thyroid peroxidase antibody positivity,	1.0E-9	rs653178	downstream	-28999	Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease.
12:112007756	Peripheral artery disease,	6.0E-7	rs653178	downstream	-28999	The ATXN2-SH2B3 locus is associated with peripheral arterial disease: an electronic medical record-based genome-wide association study.
12:112007756	Alopecia areata,	2.0E-7	rs653178	downstream	-28999	Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci.
12:112007756	Type 1 diabetes,	2.0E-44	rs653178	downstream	-28999	Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers.
12:112007756	Tonsillectomy,	4.0E-10	rs653178	downstream	-28999	Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections.
12:112007756	Mean arterial pressure,	1.0E-23	rs653178	downstream	-28999	Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait loci.
12:112007756	Alanine aminotransferase levels,	3.0E-25	rs653178	downstream	-28999	Genetics of 35 blood and urine biomarkers in the UK Biobank.
12:112007756	Total cholesterol levels,	1.0E-33	rs653178	downstream	-28999	Genetics of 35 blood and urine biomarkers in the UK Biobank.
12:112007756	Cholesteryl esters to total lipids ratio in IDL,	2.0E-8	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Cholesterol levels in IDL,	2.0E-14	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Free cholesterol levels in IDL,	4.0E-14	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Serum albumin levels,	4.0E-20	rs653178	downstream	-28999	Genetics of 35 blood and urine biomarkers in the UK Biobank.
12:112007756	Cortical thickness,	1.0E-17	rs653178	downstream	-28999	Vertex-wise multivariate genome-wide association study identifies 780 unique genetic loci associated with cortical morphology.
12:112007756	Cystatin C levels,	3.0E-174	rs653178	downstream	-28999	Genetics of 35 blood and urine biomarkers in the UK Biobank.
12:112007756	Direct bilirubin levels,	2.0E-40	rs653178	downstream	-28999	Genetics of 35 blood and urine biomarkers in the UK Biobank.
12:112007756	Cholesterol levels in large HDL,	1.0E-8	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Serum alkaline phosphatase levels,	9.0E-23	rs653178	downstream	-28999	Genetics of 35 blood and urine biomarkers in the UK Biobank.
12:112007756	Whole brain free water diffusion (multivariate analysis),	2.0E-19	rs653178	downstream	-28999	Multivariate genome-wide association study on tissue-sensitive diffusion metrics highlights pathways that shape the human brain.
12:112007756	Phospholipids to total lipids ratio in large HDL,	9.0E-10	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Aspartate aminotransferase levels,	3.0E-17	rs653178	downstream	-28999	Genetics of 35 blood and urine biomarkers in the UK Biobank.
12:112007756	Cystatin C plasma levels,	3.0E-239	rs653178	downstream	-28999	Pathway Association Studies Reveal Gene Loci and Pathway Networks that Associated With Plasma Cystatin C Levels.
12:112007756	Total cholines levels,	3.0E-10	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Apolipoprotein B levels,	4.0E-12	rs653178	downstream	-28999	Genetics of 35 blood and urine biomarkers in the UK Biobank.
12:112007756	Vertex-wise sulcal depth,	2.0E-35	rs653178	downstream	-28999	The genetic architecture of human cortical folding.
12:112007756	Free cholesterol to total lipids ratio in large HDL,	3.0E-9	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	High density lipoprotein cholesterol levels,	8.0E-31	rs653178	downstream	-28999	Genetics of 35 blood and urine biomarkers in the UK Biobank.
12:112007756	Concentration of large HDL particles,	2.0E-8	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Apolipoprotein A1 levels,	5.0E-13	rs653178	downstream	-28999	Genetics of 35 blood and urine biomarkers in the UK Biobank.
12:112007756	Eczema,	4.0E-19	rs653178	downstream	-28999	Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
12:112007756	Lifetime smoking (without educational attainment),	1.0E-8	rs653178	downstream	-28999	Genetic Risk for Smoking: Disentangling Interplay Between Genes and Socioeconomic Status.
12:112007756	Aspartate aminotransferase to alanine aminotransferase ratio,	2.0E-12	rs653178	downstream	-28999	Genetics of 35 blood and urine biomarkers in the UK Biobank.
12:112007756	Cholesteryl ester levels in IDL,	3.0E-14	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Total lipid levels in IDL,	2.0E-13	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Phospholipid levels in IDL,	4.0E-12	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Concentration of IDL particles,	6.0E-10	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Non-albumin protein levels,	3.0E-59	rs653178	downstream	-28999	Genetics of 35 blood and urine biomarkers in the UK Biobank.
12:112007756	Low density lipoprotein cholesterol levels,	1.0E-22	rs653178	downstream	-28999	Genetics of 35 blood and urine biomarkers in the UK Biobank.
12:112007756	Vertex-wise cortical surface area,	2.0E-22	rs653178	downstream	-28999	The genetic architecture of human cortical folding.
12:112007756	Total bilirubin levels,	1.0E-56	rs653178	downstream	-28999	Genetics of 35 blood and urine biomarkers in the UK Biobank.
12:112007756	Serum phosphate levels,	1.0E-27	rs653178	downstream	-28999	Genetics of 35 blood and urine biomarkers in the UK Biobank.
12:112007756	Vertex-wise cortical thickness,	6.0E-34	rs653178	downstream	-28999	The genetic architecture of human cortical folding.
12:112007756	Cholesterol to total lipids ratio in large HDL,	4.0E-11	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Serum total protein level,	8.0E-18	rs653178	downstream	-28999	Genetics of 35 blood and urine biomarkers in the UK Biobank.
12:112007756	Kynurenine levels,	1.0E-45	rs653178	downstream	-28999	A cross-platform approach identifies genetic regulators of human metabolism and health.
12:112007756	Cholesteryl ester levels in large HDL,	1.0E-8	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Free cholesterol levels in large HDL,	2.0E-8	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Glycated hemoglobin levels,	4.0E-31	rs653178	downstream	-28999	Genetics of 35 blood and urine biomarkers in the UK Biobank.
12:112007756	Triglycerides to total lipids ratio in small LDL,	5.0E-8	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Urate levels,	1.0E-45	rs653178	downstream	-28999	Genetics of 35 blood and urine biomarkers in the UK Biobank.
12:112007756	Total phospholipid levels in lipoprotein particles,	5.0E-11	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Cholesteryl ester levels in very large HDL,	5.0E-10	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Free cholesterol to total lipids ratio in small VLDL,	1.0E-11	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Cholesterol levels in very large HDL,	2.0E-9	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Remnant cholesterol (non-HDL, Notice: Undefined offset: 1 in /var/www/html/repeats.php on line 199 non-LDL -cholesterol),	2.0E-9	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Triglycerides to total lipids ratio in medium VLDL,	4.0E-10	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Phospholipids to total lipids ratio in medium VLDL,	8.0E-10	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Cholesteryl ester levels in medium VLDL,	5.0E-10	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Cholesterol levels in medium VLDL,	4.0E-9	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Free cholesterol to total lipids ratio in medium VLDL,	2.0E-11	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Cholesterol to total lipids ratio in medium VLDL,	9.0E-10	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Lymphocyte percentage of white cells,	2.0E-75	rs653178	downstream	-28999	The Polygenic and Monogenic Basis of Blood Traits and Diseases.
12:112007756	Concentration of very large HDL particles,	8.0E-9	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Phospholipids to total lipids ratio in small VLDL,	4.0E-12	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Sphingomyelin levels,	8.0E-15	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Cholesterol levels in very small VLDL,	7.0E-9	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Triglycerides to total lipids ratio in very small VLDL,	3.0E-10	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Total free cholesterol levels,	1.0E-12	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Cholesteryl esters to total lipids ratio in very small VLDL,	2.0E-10	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Cholesteryl ester levels in very small VLDL,	1.0E-9	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Total cholesterol levels,	5.0E-14	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Total esterified cholesterol levels,	2.0E-14	rs653178	downstream	-28999	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112007756	Neutrophil percentage of white cells,	8.0E-111	rs653178	downstream	-28999	The Polygenic and Monogenic Basis of Blood Traits and Diseases.
12:112013941	Platelet count,	1.0E-23	rs61941261	downstream	-22814	The Polygenic and Monogenic Basis of Blood Traits and Diseases.
12:112013944	Plateletcrit,	2.0E-9	rs61941262	downstream	-22811	The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
12:112013944	Serum albumin levels,	7.0E-21	rs61941262	downstream	-22811	A cross-population atlas of genetic associations for 220 human phenotypes.
12:112016920	Platelet count,	2.0E-16	rs138281696	downstream	-19835	Genetic determinants of blood-cell traits influence susceptibility to childhood acute lymphoblastic leukemia.
12:112020793	Caffeine consumption from coffee or tea,	9.0E-10	rs376877108	downstream	-15962	Associations of Observational and Genetically Determined Caffeine Intake With Coronary Artery Disease and Diabetes Mellitus.
12:112023067	Platelet distribution width,	4.0E-12	rs11065961	downstream	-13688	The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
12:112023067	Concentration of large LDL particles,	3.0E-10	rs11065961	downstream	-13688	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112023067	Plateletcrit,	7.0E-209	rs11065961	downstream	-13688	The Polygenic and Monogenic Basis of Blood Traits and Diseases.
12:112023067	Triglycerides to total lipids ratio in small VLDL,	1.0E-9	rs11065961	downstream	-13688	Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
12:112024096	Red blood cell count,	3.0E-23	rs540244401	downstream	-12659	The Polygenic and Monogenic Basis of Blood Traits and Diseases.
12:112032570	Eosinophil counts,	1.0E-18	rs145618127	downstream	-4185	Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
12:112036797	Platelet count,	8.0E-18	rs4098854	upstream	42	The Polygenic and Monogenic Basis of Blood Traits and Diseases.
12:112037000	Mean spheric corpuscular volume,	1.0E-15	rs695871	upstream	245	The Polygenic and Monogenic Basis of Blood Traits and Diseases.
12:112037526	Hemoglobin,	4.0E-13	rs10849962	upstream	771	The Polygenic and Monogenic Basis of Blood Traits and Diseases.
12:112058267	Body mass index,	6.0E-9	rs149673355	upstream	21512	A cross-population atlas of genetic associations for 220 human phenotypes.
12:112059557	Systolic blood pressure x alcohol consumption interaction (2df test),	2.0E-22	rs11065979	upstream	22802	Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries.
12:112059557	Diastolic blood pressure x alcohol consumption interaction (2df test),	2.0E-45	rs11065979	upstream	22802	Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries.
12:112059557	Mean arterial pressure x alcohol consumption interaction (2df test),	2.0E-14	rs11065979	upstream	22802	Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries.
12:112059557	Mean arterial pressure x alcohol consumption interaction (2df test),	1.0E-11	rs11065979	upstream	22802	Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries.
12:112059557	Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),	1.0E-16	rs11065979	upstream	22802	Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries.
12:112059557	Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),	4.0E-21	rs11065979	upstream	22802	Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries.
12:112059557	Small vessel stroke (CCSp classification),	9.0E-9	rs11065979	upstream	22802	Alternate approach to stroke phenotyping identifies a genetic risk locus for small vessel stroke.
12:112059557	Diastolic blood pressure,	5.0E-8	rs11065979	upstream	22802	Genetic analyses of diverse populations improves discovery for complex traits.
12:112059557	Asthma onset (childhood vs adult),	2.0E-7	rs11065979	upstream	22802	Genetic Architectures of Childhood- and Adult-Onset Asthma Are Partly Distinct.
12:112059557	Asthma (childhood onset),	5.0E-18	rs11065979	upstream	22802	Genetic Architectures of Childhood- and Adult-Onset Asthma Are Partly Distinct.
12:112059557	Asthma,	3.0E-7	rs11065979	upstream	22802	Genetic Architectures of Childhood- and Adult-Onset Asthma Are Partly Distinct.
12:112059557	CD64 on CD14+ CD16+ monocyte,	6.0E-9	rs11065979	upstream	22802	Complex genetic signatures in immune cells underlie autoimmunity and inform therapy.
12:112059557	Primary biliary cirrhosis,	3.0E-9	rs11065979	upstream	22802	Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis.
12:112059557	White blood cell count (basophil),	1.0E-12	rs11065979	upstream	22802	The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
12:112059557	Psoriasis,	2.0E-8	rs11065979	upstream	22802	Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants.
12:112059557	Parental lifespan,	1.0E-12	rs11065979	upstream	22802	Genomics of 1 million parent lifespans implicates novel pathways and common diseases and distinguishes survival chances.
12:112059557	Intraocular pressure,	3.0E-9	rs11065979	upstream	22802	Genome-wide association study of intraocular pressure uncovers new pathways to glaucoma.
12:112059557	Cancer (pleiotropy),	5.0E-6	rs11065979	upstream	22802	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.
12:112059557	Blood protein levels,	2.0E-12	rs11065979	upstream	22802	Genomic atlas of the human plasma proteome.
12:112059557	Parental longevity (combined parental attained age, Notice: Undefined offset: 1 in /var/www/html/repeats.php on line 199 Martingale residuals),	2.0E-12	rs11065979	upstream	22802	Human longevity: 25 genetic loci associated in 389,166 UK biobank participants.
12:112059557	Diastolic blood pressure,	3.0E-8	rs11065979	upstream	22802	Variant Discovery and Fine Mapping of Genetic Loci Associated with Blood Pressure Traits in Hispanics and African Americans.
12:112059557	Waist-to-hip ratio adjusted for BMI,	2.0E-8	rs11065979	upstream	22802	GWAS of allometric body-shape indices in UK Biobank identifies loci suggesting associations with morphogenesis, organogenesis, adrenal cell renewal and cancer.
12:112061723	hemolysis of donated blood (osmotic),	2.0E-13	rs77684561	upstream	24968	Multi-ancestry genome-wide association study identifies 27 loci associated with measures of hemolysis following blood storage.
12:112061723	hemolysis of donated blood (osmotic),	5.0E-8	rs77684561	upstream	24968	Multi-ancestry genome-wide association study identifies 27 loci associated with measures of hemolysis following blood storage.
12:112065795	Body mass index,	2.0E-9	rs11065983	upstream	29040	A cross-population atlas of genetic associations for 220 human phenotypes.
12:112069836	Sex hormone-binding globulin levels adjusted for BMI,	1.0E-10	rs183015141	upstream	33081	Using human genetics to understand the disease impacts of testosterone in men and women.
12:112069836	Sex hormone-binding globulin levels,	1.0E-11	rs183015141	upstream	33081	Using human genetics to understand the disease impacts of testosterone in men and women.
12:112072243	Platelet count,	9.0E-9	rs12319170	upstream	35488	Multi-ethnic genome-wide association analyses of white blood cell and platelet traits in the Population Architecture using Genomics and Epidemiology (PAGE) study.
12:112072424	Hemoglobin levels,	6.0E-135	rs11065987	upstream	35669	Predicted loss and gain of function mutations in ACO1 are associated with erythropoiesis.
12:112072424	Body mass index,	1.0E-6	rs11065987	upstream	35669	Genetic studies of body mass index yield new insights for obesity biology.
12:112072424	Body mass index,	1.0E-6	rs11065987	upstream	35669	Genetic studies of body mass index yield new insights for obesity biology.
12:112072424	Hematocrit,	1.0E-8	rs11065987	upstream	35669	Genome-wide Trans-ethnic Meta-analysis Identifies Seven Genetic Loci Influencing Erythrocyte Traits and a Role for RBPMS in Erythropoiesis.
12:112072424	Body mass index,	2.0E-11	rs11065987	upstream	35669	The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study.
12:112072424	Asthma,	3.0E-8	rs11065987	upstream	35669	Genome-wide analysis highlights contribution of immune system pathways to the genetic architecture of asthma.
12:112072424	Body mass index,	4.0E-9	rs11065987	upstream	35669	A Large Multi-ethnic Genome-Wide Association Study of Adult Body Mass Index Identifies Novel Loci.
12:112072424	Hemoglobin,	1.0E-11	rs11065987	upstream	35669	Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium.
12:112072424	Hematocrit,	1.0E-12	rs11065987	upstream	35669	Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium.
12:112072424	Cholesterol, Notice: Undefined offset: 1 in /var/www/html/repeats.php on line 199 total,	7.0E-12	rs11065987	upstream	35669	Biological, clinical and population relevance of 95 loci for blood lipids.
12:112072424	LDL cholesterol,	2.0E-9	rs11065987	upstream	35669	Biological, clinical and population relevance of 95 loci for blood lipids.
12:112072424	Coronary artery disease or ischemic stroke,	4.0E-14	rs11065987	upstream	35669	Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants.
12:112072424	Coronary artery disease or large artery stroke,	3.0E-10	rs11065987	upstream	35669	Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants.
12:112072424	Tetralogy of Fallot,	8.0E-11	rs11065987	upstream	35669	Genome-wide association study identifies loci on 12q24 and 13q32 associated with tetralogy of Fallot.
12:112072424	Primary biliary cholangitis,	3.0E-8	rs11065987	upstream	35669	International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways.
12:112072424	LDL cholesterol,	1.0E-11	rs11065987	upstream	35669	Discovery and refinement of loci associated with lipid levels.
12:112072424	Cholesterol, Notice: Undefined offset: 1 in /var/www/html/repeats.php on line 199 total,	2.0E-16	rs11065987	upstream	35669	Discovery and refinement of loci associated with lipid levels.
12:112072424	High density lipoprotein cholesterol levels,	4.0E-7	rs11065987	upstream	35669	A large electronic-health-record-based genome-wide study of serum lipids.
12:112072424	High density lipoprotein cholesterol levels,	1.0E-7	rs11065987	upstream	35669	A large electronic-health-record-based genome-wide study of serum lipids.
12:112072424	Low density lipoprotein cholesterol levels,	9.0E-10	rs11065987	upstream	35669	A large electronic-health-record-based genome-wide study of serum lipids.
12:112072424	Low density lipoprotein cholesterol levels,	6.0E-10	rs11065987	upstream	35669	A large electronic-health-record-based genome-wide study of serum lipids.
12:112072424	Total cholesterol levels,	1.0E-10	rs11065987	upstream	35669	A large electronic-health-record-based genome-wide study of serum lipids.
12:112072424	Total cholesterol levels,	3.0E-10	rs11065987	upstream	35669	A large electronic-health-record-based genome-wide study of serum lipids.
12:112072424	Cancer,	2.0E-6	rs11065987	upstream	35669	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.
12:112074677	Neutrophil percentage of white cells,	4.0E-9	rs550685946	upstream	37922	The Polygenic and Monogenic Basis of Blood Traits and Diseases.
12:112083162	Eosinophil counts,	0	rs11065991	upstream	46407	Trans-ethnic and Ancestry-Specific Blood-Cell Genetics in 746,667 Individuals from 5 Global Populations.

Position	HGVS	dbSNP id	Phenotype List	Distance	Clinvar Significance
12:111990161	NM_001372574.1(ATXN2):c.494T>C (p.Met165Thr)	NA	Spinocerebellar ataxia type 2	-46594	Uncertain significance
12:111992031	NM_001372574.1(ATXN2):c.289-11dup	rs144235483	Spinocerebellar ataxia type 2\|not specified	-44724	Benign
12:111992032	NM_001372574.1(ATXN2):c.289-11del	rs144235483	Spinocerebellar ataxia type 2\|not specified	-44723	Benign/Likely benign
12:112001017	GRCh37/hg19 12q24.12(chr12:112001017-112037450)x3	NA	not provided	-35738	Benign
12:112035918	GRCh37/hg19 12q24.12(chr12:112035918-112037191)x1	NA	not provided	-837	Benign
12:112036649	NM_001372574.1(ATXN2):c.176_190del (p.Val59_Ser63del)	rs778119853	GM3 synthase deficiency	-106	Uncertain significance
12:112036754	NM_001372574.1(ATXN2):c.59AGC[8] (p.Gln28del)	rs10560189	Spinocerebellar ataxia type 2\|not specified	-1	Benign
12:112036782	NM_001372574.1(ATXN2):c.57A>G (p.Gln19=)	rs76696028	Spinocerebellar ataxia type 2\|not specified	27	Benign/Likely benign
12:112036782	NM_001372574.1(ATXN2):c.18GCA[28] (p.Gln14_Gln28dup)	rs193922927	Amyotrophic lateral sclerosis	27	risk factor
12:112036797	NM_001372574.1(ATXN2):c.42G>A (p.Gln14=)	rs4098854	not specified\|Spinocerebellar ataxia type 2	42	Benign/Likely benign
12:112036797	NM_001372574.1(ATXN2):c.42G>A (p.Gln14=)	rs4098854	not specified\|Spinocerebellar ataxia type 2	42	Benign/Likely benign
12:112036809	NM_001372574.1(ATXN2):c.30G>A (p.Gln10=)	rs746918429	not provided	54	Uncertain significance
12:112036927	NM_001372574.1(ATXN2):c.-89C>T	NA	not provided	172	Uncertain significance
12:112036929	NM_001372574.1(ATXN2):c.-91C>T	rs695872	not specified\|Spinocerebellar ataxia type 2	174	Benign/Likely benign
12:112036929	NM_001372574.1(ATXN2):c.-91C>T	rs695872	not specified\|Spinocerebellar ataxia type 2	174	Benign/Likely benign
12:112037000	NM_001372574.1(ATXN2):c.-162C>G	rs695871	not specified\|Spinocerebellar ataxia type 2	245	Benign/Likely benign
12:112037000	NM_001372574.1(ATXN2):c.-162C>G	rs695871	not specified\|Spinocerebellar ataxia type 2	245	Benign/Likely benign
12:112037014	NM_001372574.1(ATXN2):c.-176G>C	rs864309580	not specified	259	Benign
12:112037014	NM_001372574.1(ATXN2):c.-176G>C	rs864309580	not specified	259	Benign
12:112037104	NM_001372574.1(ATXN2):c.-266C>T	rs536609944	Spinocerebellar ataxia type 2	349	Uncertain significance

Position	Population	BlockLength (kb)	Distance	Location with respect to STR	No. of SNPs	SNPs in the Haploblock
12:111988432-111996557	all_pop	8.126	-48323	downstream	16	rs625093, rs638791, rs666727, rs641084, rs848132, rs58937998, rs12315171, rs7311293, rs10645847, rs7969300, rs593226, rs569009135, rs11065950, rs12301021, rs11065951, rs65510,
12:111988432-111993886	AMR	5.455	-48323	downstream	8	rs625093, rs638791, rs666727, rs641084, rs848132, rs58937998, rs7969300, rs59322,
12:111997023-112013935	all_pop	16.913	-39732	downstream	33	rs642536, rs848129, rs7308857, rs610769, rs73414453, rs9971826, rs9971887, rs595529, rs13377932, rs11065953, rs60443842, rs7137348, rs11330026, rs616559, rs616513, rs11065954, rs10849958, rs28823331, rs575810563, rs10774626, rs77001757, rs12314647, rs7953144, rs7964354, rs653178, rs77110671, rs650887, rs16941578, rs7972340, rs57081594, rs848130, rs532298109, rs11282955,
12:111997023-111997502	AMR	0.48	-39732	downstream	2	rs642536, rs84812,
12:111997023-112010205	EAS	13.183	-39732	downstream	14	rs642536, rs848129, rs610769, rs595529, rs11065953, rs616559, rs616513, rs10849958, rs575810563, rs10774626, rs650887, rs57081594, rs848130, rs53229810,
12:111997023-112016016	EUR	18.994	-39732	downstream	18	rs642536, rs848129, rs610769, rs595529, rs616559, rs616513, rs615134, rs575810563, rs653178, rs650887, rs848130, rs532298109, rs61944391, rs61941261, rs61941262, rs12816310, rs60506035, rs739870,
12:111997023-112010205	SAS	13.183	-39732	downstream	16	rs642536, rs848129, rs610769, rs595529, rs11065953, rs616559, rs616513, rs10849958, rs575810563, rs10774626, rs653178, rs650887, rs16941580, rs57081594, rs848130, rs53229810,
12:111999570-112009831	AMR	10.262	-37185	downstream	15	rs610769, rs595529, rs11065953, rs4766464, rs11330026, rs616559, rs616513, rs615134, rs10849958, rs575810563, rs10774626, rs653178, rs650887, rs57081594, rs84813,
12:112013935-112013941	AFR	0.007	-22820	downstream	3	rs112829556, rs61944391, rs6194126,
12:112013937-112013944	all_pop	0.008	-22818	downstream	3	rs61944391, rs61941261, rs6194126,
12:112013937-112013944	AMR	0.008	-22818	downstream	3	rs61944391, rs61941261, rs6194126,
12:112013937-112013944	EAS	0.008	-22818	downstream	3	rs61944391, rs61941261, rs6194126,
12:112013937-112013944	SAS	0.008	-22818	downstream	3	rs61944391, rs61941261, rs6194126,
12:112013944-112017562	AFR	3.619	-22811	downstream	8	rs61941262, rs12816310, rs113485398, rs146415388, rs7301158, rs60506035, rs7398705, rs729810,
12:112014051-112017562	all_pop	3.512	-22704	downstream	8	rs118002600, rs12816310, rs113485398, rs146415388, rs7301158, rs60506035, rs7398705, rs729810,
12:112014051-112015259	AMR	1.209	-22704	downstream	3	rs118002600, rs12816310, rs730115,
12:112014051-112016016	EAS	1.966	-22704	downstream	5	rs118002600, rs12816310, rs7301158, rs60506035, rs739870,
12:112014501-112016016	SAS	1.516	-22254	downstream	4	rs12816310, rs7301158, rs60506035, rs739870,
12:112015824-112016016	AMR	0.193	-20931	downstream	2	rs60506035, rs739870,
12:112018554-112038117	AFR	19.564	-18201	downstream	53	rs11065956, rs11065957, rs11065958, rs6490216, rs12369009, rs10774629, rs375687566, rs144032673, rs374845735, rs113761435, rs144924229, rs56945768, rs11065959, rs10774631, rs11065960, rs11065961, rs73414496, rs11065963, rs112336421, rs11065965, rs545179860, rs11065967, rs77640557, rs12308744, rs532382837, rs7398196, rs112009841, rs111717860, rs575208285, rs142968380, rs113075607, rs149062199, rs60473879, rs7953810, rs111962129, rs142496500, rs147220906, rs58350765, rs538419890, rs141156220, rs73414502, rs114313107, rs115357525, rs12313759, rs113730273, rs73416404, rs143599937, rs10560189, rs4098854, rs695872, rs695871, rs10849962, rs1230855,
12:112018554-112034753	all_pop	16.2	-18201	downstream	38	rs11065956, rs11065957, rs11065958, rs6490216, rs12369009, rs10774629, rs375687566, rs374845735, rs144924229, rs56945768, rs11065959, rs10774631, rs11065960, rs11065961, rs73414496, rs11065963, rs112336421, rs11065965, rs545179860, rs11065967, rs77640557, rs12308744, rs532382837, rs7398196, rs112009841, rs111717860, rs575208285, rs113075607, rs149062199, rs60473879, rs7953810, rs111962129, rs142496500, rs58350765, rs538419890, rs73414502, rs73416404, rs14359993,
12:112019799-112020214	AMR	0.416	-16956	downstream	2	rs12369009, rs1077462,
12:112019799-112020214	EAS	0.416	-16956	downstream	2	rs12369009, rs1077462,
12:112019799-112020214	EUR	0.416	-16956	downstream	2	rs12369009, rs1077462,
12:112019799-112020214	SAS	0.416	-16956	downstream	2	rs12369009, rs1077462,
12:112020797-112029291	AMR	8.495	-15958	downstream	10	rs374845735, rs11065959, rs10774631, rs11065960, rs11065961, rs11065963, rs11065965, rs11065967, rs7398196, rs795381,
12:112020797-112038676	EAS	17.88	-15958	downstream	18	rs374845735, rs11065959, rs10774631, rs11065960, rs11065961, rs11065963, rs11065965, rs11065967, rs7398196, rs7953810, rs190705783, rs111962129, rs4098854, rs695872, rs695871, rs10849962, rs59281986, rs1281045,
12:112020797-112037526	EUR	16.73	-15958	downstream	12	rs374845735, rs10774631, rs11065961, rs11065967, rs7398196, rs142170016, rs7953810, rs4098854, rs695872, rs695871, rs117532831, rs1084996,
12:112020797-112029291	SAS	8.495	-15958	downstream	11	rs374845735, rs11065959, rs10774631, rs11065960, rs11065961, rs11065963, rs11065965, rs11065967, rs532382837, rs7398196, rs795381,
12:112036929-112038117	all_pop	1.189	174	upstream	4	rs695872, rs695871, rs10849962, rs1230855,
12:112036929-112037526	AMR	0.598	174	upstream	3	rs695872, rs695871, rs1084996,
12:112036929-112037526	SAS	0.598	174	upstream	3	rs695872, rs695871, rs1084996,
12:112038332-112039298	AFR	0.967	1577	upstream	5	rs12316988, rs12296408, rs12810456, rs6490230, rs649023,
12:112038332-112038739	all_pop	0.408	1577	upstream	4	rs12316988, rs12296408, rs12810456, rs36779768,
12:112039188-112039298	all_pop	0.111	2433	upstream	2	rs6490230, rs649023,
12:112040949-112055560	AFR	14.612	4194	upstream	22	rs12300359, rs112022408, rs566952773, rs12314610, rs79779335, rs139177341, rs3809274, rs2339818, rs7484754, rs11065976, rs11836377, rs7302114, rs12319091, rs12299336, rs58734088, rs76741465, rs2339827, rs550871698, rs66480035, rs2051793, rs10849963, rs7666702,
12:112040949-112052651	all_pop	11.703	4194	upstream	15	rs12300359, rs112022408, rs566952773, rs3809274, rs76896073, rs2339818, rs7484754, rs11065976, rs11836377, rs7302114, rs12319091, rs76741465, rs2339827, rs550871698, rs6648003,
12:112042033-112055560	EAS	13.528	5278	upstream	12	rs566952773, rs3809274, rs2339818, rs7484754, rs11065976, rs7302114, rs76741465, rs550871698, rs66480035, rs2051793, rs10849963, rs7666702,
12:112042033-112054760	SAS	12.728	5278	upstream	15	rs566952773, rs3809274, rs76896073, rs2339818, rs7484754, rs11065976, rs145329290, rs7302114, rs142702160, rs76741465, rs2339827, rs550871698, rs66480035, rs2051793, rs7108318,
12:112044333-112055560	AMR	11.228	7578	upstream	15	rs3809274, rs151328957, rs2339818, rs7484754, rs11065976, rs7302114, rs76741465, rs190789534, rs2339827, rs550871698, rs66480035, rs2051793, rs71083184, rs10849963, rs7666702,
12:112044333-112055560	EUR	11.228	7578	upstream	12	rs3809274, rs2339818, rs7484754, rs11065976, rs145329290, rs76741465, rs2339827, rs550871698, rs66480035, rs71083184, rs10849963, rs7666702,
12:112053772-112055560	all_pop	1.789	17017	upstream	4	rs2051793, rs71083184, rs10849963, rs7666702,
12:112054977-112055560	SAS	0.584	18222	upstream	2	rs10849963, rs7666702,
12:112057774-112062875	AFR	5.102	21019	upstream	12	rs35662736, rs149673355, rs11065977, rs145488714, rs200696839, rs149502112, rs11065980, rs11613441, rs12305105, rs77684561, rs10082755, rs154439,
12:112057774-112062875	all_pop	5.102	21019	upstream	11	rs35662736, rs149673355, rs11065977, rs145488714, rs11065979, rs11065980, rs11613441, rs12305105, rs77684561, rs10082755, rs154439,
12:112057774-112062875	AMR	5.102	21019	upstream	11	rs35662736, rs149673355, rs11065977, rs145488714, rs11065979, rs190629846, rs11065980, rs11613441, rs12305105, rs77684561, rs154439,
12:112057774-112061723	EAS	3.95	21019	upstream	7	rs35662736, rs149673355, rs11065977, rs11065980, rs11613441, rs12305105, rs7768456,
12:112057774-112072424	SAS	14.651	21019	upstream	20	rs35662736, rs149673355, rs11065977, rs145488714, rs11065979, rs11065980, rs11613441, rs12305105, rs77684561, rs1544396, rs557389470, rs9300319, rs11065983, rs76579145, rs7972674, rs559923202, rs10849964, rs186714617, rs73416497, rs1106598,
12:112059557-112067387	EUR	7.831	22802	upstream	8	rs11065979, rs11065980, rs11613441, rs77684561, rs1544396, rs557389470, rs9300319, rs797267,
12:112062875-112126615	EAS	63.741	26120	upstream	45	rs1544396, rs9300319, rs11065983, rs76579145, rs7972674, rs10849964, rs73416497, rs147034578, rs3809276, rs3840796, rs74411430, rs141088484, rs11065992, rs57186456, rs10774632, rs10744773, rs11065993, rs12582964, rs12579287, rs2285727, rs7977828, rs12307990, rs10744775, rs10774633, rs10774634, rs10774635, rs10849966, rs3742001, rs3803171, rs565349424, rs570600621, rs3782886, rs12427276, rs7136874, rs11065999, rs567878380, rs11336940, rs146114438, rs847895, rs11066001, rs646275, rs12580069, rs601663, rs649406, rs60881,
12:112063722-112067387	AFR	3.666	26967	upstream	6	rs113981020, rs9300319, rs1965008, rs76579145, rs73416490, rs797267,
12:112064897-112068438	all_pop	3.542	28142	upstream	6	rs9300319, rs11065983, rs76579145, rs7972674, rs559923202, rs1084996,
12:112064897-112067387	AMR	2.491	28142	upstream	4	rs9300319, rs11065983, rs76579145, rs797267,
12:112069389-112072424	all_pop	3.036	32634	upstream	4	rs186714617, rs73416497, rs12319170, rs1106598,
12:112070869-112072696	AFR	1.828	34114	upstream	4	rs75120850, rs73416497, rs12319170, rs55509080,
12:112070977-112072424	AMR	1.448	34222	upstream	2	rs73416497, rs1106598,
12:112070977-112072424	EUR	1.448	34222	upstream	2	rs73416497, rs1106598,
12:112073524-112073916	AFR	0.393	36769	upstream	2	rs76445107, rs380927,
12:112073916-112113850	all_pop	39.935	37161	upstream	33	rs3809276, rs3840796, rs74411430, rs141088484, rs11065991, rs11065992, rs112870399, rs57186456, rs10774632, rs10744773, rs11065993, rs118106280, rs10744774, rs12582964, rs12579287, rs2285727, rs73418315, rs7977828, rs12307990, rs10849965, rs10744775, rs10774633, rs117283696, rs10774634, rs10774635, rs10849966, rs3742001, rs3803171, rs565349424, rs570600621, rs12427276, rs7136874, rs1106599,
12:112073916-112126615	AMR	52.7	37161	upstream	42	rs3809276, rs3840796, rs74411430, rs141088484, rs11065991, rs57186456, rs10774632, rs10744773, rs11065993, rs10744774, rs12582964, rs12579287, rs2285727, rs7977828, rs12307990, rs10744775, rs10774633, rs1419586, rs10774634, rs10774635, rs10849966, rs3742001, rs3803171, rs565349424, rs150818430, rs570600621, rs182022078, rs12427276, rs7136874, rs11065999, rs200597303, rs567878380, rs4767336, rs11336940, rs146114438, rs847895, rs646275, rs12580069, rs618210, rs601663, rs649406, rs60881,
12:112073916-112113658	EUR	39.743	37161	upstream	22	rs3809276, rs141088484, rs11065991, rs57186456, rs10774632, rs10744773, rs10744774, rs12582964, rs12579287, rs17628828, rs2285727, rs7977828, rs10744775, rs1419586, rs10774634, rs10849966, rs3742001, rs565349424, rs138688819, rs570600621, rs12427276, rs713687,
12:112073916-112113850	SAS	39.935	37161	upstream	31	rs3809276, rs3840796, rs74411430, rs141088484, rs11065991, rs57186456, rs10774632, rs10744773, rs11065993, rs118106280, rs10744774, rs12582964, rs12579287, rs17628828, rs534374765, rs2285727, rs7977828, rs12307990, rs10744775, rs10774633, rs117283696, rs10774634, rs10774635, rs10849966, rs3742001, rs3803171, rs565349424, rs570600621, rs12427276, rs7136874, rs1106599,
12:112075295-112077251	AFR	1.957	38540	upstream	2	rs116076389, rs1230179,
12:112077884-112190412	AFR	112.529	41129	upstream	329	rs55884098, rs145196099, rs150271150, rs141088484, rs76621364, rs79269527, rs59185961, rs77913600, rs78238613, rs143929470, rs148617821, rs7134633, rs115039455, rs60086337, rs112870399, rs145831018, rs57186456, rs10774632, rs557255995, rs10744773, rs79280544, rs59800733, rs61739319, rs56061769, rs75122732, rs145907174, rs111761278, rs112234420, rs80337646, rs12582964, rs12579287, rs59265267, rs561149317, rs148245571, rs2285727, rs7977304, rs7971818, rs73418315, rs7977828, rs73418318, rs56085333, rs12307990, rs75384652, rs10849965, rs10744775, rs10774633, rs566432692, rs7965252, rs7977023, rs574047287, rs10774634, rs142038347, rs10774635, rs10849966, rs113750942, rs12304674, rs78641124, rs80178062, rs3742001, rs79921733, rs61999323, rs57296855, rs59790566, rs3803171, rs140102960, rs188868097, rs138114250, rs59718849, rs144816685, rs7955941, rs7966892, rs140225873, rs111468734, rs7138979, rs570600621, rs111736223, rs79358450, rs113169767, rs146305699, rs114817792, rs76382880, rs76620590, rs73418393, rs144407522, rs77509231, rs56076826, rs12427276, rs7136874, rs77342832, rs11065999, rs76509230, rs76383979, rs56165378, rs78101219, rs78457020, rs76636966, rs61308437, rs112550693, rs567878380, rs75117773, rs11336940, rs146114438, rs847895, rs139563380, rs143193255, rs77974911, rs646275, rs12580069, rs16941620, rs78019498, rs58580157, rs7299380, rs601663, rs61561567, rs61315691, rs142007647, rs649406, rs60694720, rs608814, rs76914881, rs74673332, rs114609837, rs115334703, rs77500230, rs112377122, rs28680388, rs540935938, rs7980705, rs7971739, rs12315456, rs7977719, rs58881081, rs11066002, rs659964, rs80352379, rs78909071, rs77123766, rs74762902, rs7132509, rs75710754, rs632650, rs78391424, rs11066003, rs148866836, rs143561415, rs618358, rs617044, rs56240406, rs602276, rs7959942, rs147434813, rs695047, rs77177960, rs76037738, rs57748028, rs666951, rs75456659, rs75812910, rs57369943, rs77813513, rs150723991, rs592311, rs642898, rs138603728, rs145548072, rs682212, rs114984678, rs554829011, rs187043022, rs144304782, rs61309518, rs56750693, rs12310926, rs141051543, rs149820343, rs61084633, rs57072497, rs200037659, rs627308, rs609230, rs608848, rs35276160, rs35753710, rs79425161, rs150771041, rs77585612, rs77757448, rs113412718, rs56307976, rs35030891, rs592967, rs112381390, rs193017167, rs847888, rs77392966, rs147580273, rs188216336, rs145517258, rs78200657, rs57721697, rs7312254, rs74915934, rs141853815, rs11066010, rs7295406, rs560344796, rs113983443, rs78909946, rs140102070, rs115352431, rs148637426, rs11503168, rs7969271, rs77342129, rs551878144, rs688920, rs114716337, rs146506479, rs76395881, rs144752992, rs76245526, rs147545702, rs630616, rs12302800, rs573993820, rs1100130, rs528534506, rs544079390, rs540445337, rs1100129, rs1100127, rs680135, rs556405074, rs374895437, rs658051, rs551372551, rs549088993, rs567502627, rs571531438, rs375514595, rs140124689, rs143979754, rs847898, rs146525054, rs115922503, rs113697473, rs143418951, rs61675993, rs634819, rs594570, rs634389, rs144107545, rs74446006, rs35358426, rs58598790, rs624716, rs78705199, rs145936434, rs113225575, rs79872508, rs59844708, rs75063348, rs640783, rs79061554, rs55864357, rs57761542, rs114001934, rs668774, rs113433473, rs78226348, rs76261196, rs76918876, rs73420444, rs74669905, rs142465173, rs7975114, rs847900, rs570822176, rs75182985, rs78112811, rs35716113, rs80351850, rs78006345, rs143225406, rs648300, rs669148, rs80079426, rs56311763, rs58759066, rs144710904, rs78886810, rs78780135, rs56310777, rs58203141, rs77941328, rs115544233, rs114572920, rs75454591, rs60350179, rs7962138, rs61228394, rs75391425, rs7301464, rs59905228, rs138622714, rs115382014, rs73420459, rs7309076, rs115117481, rs4767694, rs11066018, rs112137096, rs11066019, rs543409899, rs7303864, rs7136739, rs73420467, rs75197003, rs78455539, rs75138525, rs75655687, rs35309453, rs146063790, rs11608345, rs16941634, rs115368534, rs78998915, rs7964201, rs1063801,

Conservation score was not calculated